Published in J Invest Dermatol on August 01, 1999
The role of the TGF-β family in wound healing, burns and scarring: a review. Int J Burns Trauma (2012) 1.74
A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med (1995) 2.88
Prospective multicenter study on CA 125 in postmenopausal pelvic masses. Gynecol Oncol (1994) 2.38
BRAF(V600E) mutation and the biology of papillary thyroid cancer. Endocr Relat Cancer (2008) 1.83
Reducing the occupational risk of infections for the surgeon: multicentric national survey on more than 15,000 surgical procedures. World J Surg (1997) 1.83
Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood (1999) 1.71
Age-related increase of baseline frequencies of sister chromatid exchanges, chromosome aberrations, and micronuclei in human lymphocytes. Cancer Epidemiol Biomarkers Prev (1997) 1.66
Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection. J Infect Dis (2000) 1.58
Interferon-gamma receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death. J Leukoc Biol (2001) 1.39
Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas. Int J Cancer (1995) 1.35
Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J Biol Chem (1997) 1.33
Distribution of interferon-gamma receptor in human tissues. Eur J Immunol (1992) 1.30
Incidence, diagnosis, and treatment of enteric and colorectal fistulae in patients with Crohn's disease. Ann Surg (1993) 1.30
Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? J Immunol (2000) 1.29
Xanthogranulomatous cholecystitis. Histopathological study and classification. Pathol Res Pract (1990) 1.26
Combined endoscopic treatment for cholelithiasis associated with choledocholithiasis. Surg Endosc (2005) 1.25
Multicentre experience in the treatment of burns with autologous and allogenic cultured epithelium, fresh or preserved in a frozen state. Burns (1989) 1.20
Potential requirement of a functional double-stranded RNA-dependent protein kinase (PKR) for the tumoricidal activation of macrophages by lipopolysaccharide or IFN-alpha beta, but not IFN-gamma. J Immunol (1995) 1.17
Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity. J Immunol (1988) 1.15
Interleukin 1 induction of the c-jun promoter. Proc Natl Acad Sci U S A (1993) 1.15
A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1. J Immunol (1999) 1.10
Prospective assessment of functional results after ileal J pouch-anal restorative proctocolectomy. Arch Surg (1993) 1.10
Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem Biophys Res Commun (1996) 1.08
Speed limit of the insulator-metal transition in magnetite. Nat Mater (2013) 1.08
Biochemical characterization of Trop-2, a cell surface molecule expressed by human carcinomas: formal proof that the monoclonal antibodies T16 and MOv-16 recognize Trop-2. Hybridoma (1992) 1.07
Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes. Blood (1997) 1.04
Partial trisomy of the long arm of chromosome 1 due to a familial translocation t(1;10) (q32;q26). Hum Genet (1978) 1.04
Anterior tension-free repair of recurrent inguinal hernia under local anesthesia: a 7-year experience in a teaching hospital. Ann Surg (2000) 1.04
A functional homologue of goosecoid in Drosophila. Development (1996) 1.03
Nitric oxide suppresses human T lymphocyte proliferation through IFN-gamma-dependent and IFN-gamma-independent induction of apoptosis. J Immunol (1999) 1.03
IL-2 up-regulates but IFN-gamma suppresses IL-8 expression in human monocytes. J Immunol (1993) 1.02
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. J Immunol (1999) 1.01
B19 virus infection in renal transplant recipients. J Clin Virol (2003) 1.00
[Carcinoid of the appendix. A case report]. Minerva Chir (2000) 0.98
Leishmania major: infection of human monocytes induces expression of IL-8 and MCAF. Exp Parasitol (1996) 0.95
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. J Immunol (1994) 0.95
Postsurgical medical treatment of advanced endometriosis: results of a randomized clinical trial. Am J Obstet Gynecol (1994) 0.92
High incidence of sperm sex chromosomes aneuploidies in two patients with Klinefelter's syndrome. J Clin Endocrinol Metab (1998) 0.91
Inheritable defects in interleukin-12- and interferon-gamma-mediated immunity and the TH1/TH2 paradigm in man. Allergy (1999) 0.91
Interleukin-15 activates proinflammatory and antimicrobial functions in polymorphonuclear cells. Infect Immun (1998) 0.91
Interleukin-2 and human monocyte activation. J Leukoc Biol (1995) 0.90
Serum amyloid A is an activator of PMN antimicrobial functions: induction of degranulation, phagocytosis, and enhancement of anti-Candida activity. J Leukoc Biol (2000) 0.89
Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases. Mediators Inflamm (2011) 0.89
Synthesis and biological activity of gold and tin compounds in ovarian cancer cells. Anticancer Drugs (1998) 0.88
Splenectomy influences bone marrow infiltration in patients with splenic marginal zone cell lymphoma with or without villous lymphocytes. Cancer (2001) 0.88
Communication in the neonatal intensive care unit: a continuous challenge. J Matern Fetal Neonatal Med (2012) 0.87
Establishment and characterization of a primitive neuroectodermal tumor of bone continuous cell line (LAP-35). Int J Cell Cloning (1990) 0.87
IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing. Leukemia (2009) 0.87
Cyclin D1 gene contains a cryptic promoter that is functional in human cancer cells. Genes Chromosomes Cancer (2001) 0.86
Interaction of Bartonella henselae with the murine macrophage cell line J774: infection and proinflammatory response. Infect Immun (2001) 0.86
Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease. Eur J Med Chem (2011) 0.86
Assessment of HIV-1 screening test sensitivities using serially diluted positive sera can give misleading results. Transfusion (1989) 0.85
Radioimmunoguided surgery using iodine-125-labeled biotinylated monoclonal antibodies and cold avidin. J Nucl Med (1994) 0.85
Regulation of interferon-gamma receptor (INF-gammaR) chains: a peculiar way to rule the life and death of human lymphocytes. Eur Cytokine Netw (2001) 0.85
Characterization of T-cell subsets infiltrating post-burn hypertrophic scar tissues. Burns (1998) 0.85
The role of quality control in a skin bank: tissue viability determination. Cell Tissue Bank (2002) 0.85
Giant villous adenoma of the duodenum. Br J Surg (1986) 0.84
IL-10 enhances CCL2 release and chemotaxis induced by CCL16 in human monocytes. Int J Immunopathol Pharmacol (2005) 0.84
Detection of Pneumocystis carinii by DNA amplification in human immunodeficiency virus-positive patients. Diagn Microbiol Infect Dis (1997) 0.84
Elevated thrombopoietin in plasma of burned patients without and with sepsis enhances platelet activation. J Thromb Haemost (2009) 0.84
Chromosome aberrations in hospital workers: evidence from surveillance studies in Italy (1963-1993). Am J Ind Med (1997) 0.84
High-efficiency expression gene cloning by flow cytometry. J Histochem Cytochem (1996) 0.83
The importance of blood cell-vessel wall interactions in tumour metastasis. Baillieres Clin Haematol (1993) 0.83
TNF production and hypertrophic scarring. Cell Immunol (1993) 0.83
A novel variant translocation t(2;13) (p23;q34) in Ki-1 large cell anaplastic lymphoma. Br J Haematol (1990) 0.83
Lupus nephritis after hepatitis B vaccination: an uncommon complication. Clin Nephrol (2007) 0.83
A new method for faster blood clearance in radioimmuno-guided surgery. J Nucl Biol Med (1991) 0.82
Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer. Eur J Surg Oncol (2007) 0.82
Surface expression of the IFN-gamma R2 chain is regulated by intracellular trafficking in human T lymphocytes. J Immunol (2000) 0.82
Membrane association and shedding of the GPI-anchored Ca-MOv18 antigen in human ovary carcinoma cells. Int J Cancer (1992) 0.81
Lymphokine-activated tumor inhibition in mice. Ability of a nonapeptide of the human IL-1 beta to recruit anti-tumor reactivity in recipient mice. J Immunol (1989) 0.81
Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies. Int J Cancer (1990) 0.81
Cutaneous innervation in hereditary sensory and autonomic neuropathy type IV. Neurology (2000) 0.81
Clinical experiences with keratinocyte grafts. Burns (1992) 0.81
In vitro and in vivo immune stimulating effects of a new standardized Echinacea angustifolia root extract (Polinacea). Fitoterapia (2005) 0.81
Cytogenetic analysis of hepatoblastoma: hypothesis of cytogenetic evolution in such tumors and results of a multicentric study. Cancer Genet Cytogenet (1998) 0.81
Antiproliferative activity and interactions with cell-cycle related proteins of the organotin compound triethyltin(IV)lupinylsulfide hydrochloride. Chem Biol Interact (2001) 0.80
Considerations on early surgery in the treatment of extensive burns. Scand J Plast Reconstr Surg (1979) 0.80
Activity of GH/IGF-1 axis in burn patients: comparison with normal subjects and patients with GH deficiency. J Endocrinol Invest (2002) 0.80
Pseudomonas aeruginosa clinical isolates: serotypes, resistance phenotypes and plasmid profiles. Eur J Epidemiol (1996) 0.80